Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma

Conclusions: Both VT and Trab-MMC groups are effective in reducing the IOP in cases of NVG after control of neovascularization with anti-vascular endothelial growth factor and pan retinal photocoagulation.
Source: Asia-Pacific Journal of Ophthalmology - Category: Opthalmology Tags: Original Clinical Study Source Type: research

Related Links:

AbstractPurposeTo determine the efficacy of cataract surgery alone and combined with two minimally invasive glaucoma surgery (MIGS) procedures (phaco-ELT and phaco-aiT).MethodsData was collected from 12/2007 to 02/2012 in this retrospective, non-randomized, comparative single surgery center study. Reduction in IOP and hypotensive medication (AGD), change in visual acuity, success rates, and complications were computed by comparing preoperative data with data at 1  year postoperatively.ResultsA total of 245 eyes of 245 subjects were included. Study eyes underwent phaco alone (38 eye) or combined phaco-ELT (105 eye) and...
Source: International Ophthalmology - Category: Opthalmology Source Type: research
Conditions:   Cataract;   Glaucoma Interventions:   Device: SD-OCT;   Device: OCT-A Sponsor:   University of Zurich Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
We read with great interest the article titled “Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion” by Rong and associates.1 The authors performed this work to identify the risk factors for development of neovascular glaucoma (NVG) in patients with central retinal vein occlusion (CRVO) and found worse presenting visual acui ty, presence of relative afferent pupillary defect at presentation, and systemic hypertension to be significant factors.
Source: American Journal of Ophthalmology - Category: Opthalmology Authors: Tags: Correspondence Source Type: research
Telemedicine and e-Health, Ahead of Print.
Source: Telemedicine and e-Health - Category: Information Technology Authors: Source Type: research
In conclusion, the existence of surgery-indicated CRS is a significant risk factor for the development of glaucoma, which correlated with the disease interval.
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
Eye, Published online: 13 November 2019; doi:10.1038/s41433-019-0675-9The choice of analysis of variance models in repeated measurements analysis—on the effect of glaucoma surgery on retinal structures
Source: Eye - Category: Opthalmology Authors: Source Type: research
Conclusion: Trabeculectomy is the most performed procedure at our centers. This is followed by g-probe and laser trabeculoplasty. The rate of trabeculectomy is on the decrease, while the rate of GDD is increasing. The laser procedures are also on the increase.
Source: Nigerian Journal of Clinical Practice - Category: Rural Health Authors: Source Type: research
Human Gene Therapy, Ahead of Print.
Source: Human Gene Therapy - Category: Genetics & Stem Cells Authors: Source Type: research
Eyevensys, a clinical-stage biotechnology company based in France, has developed a method to perform non-viral gene therapy in the eye, with the aim of treating ocular diseases. The system uses ocular electrotransfection to deliver therapeutic genes ...
Source: Medgadget - Category: Medical Devices Authors: Tags: Exclusive Genetics Ophthalmology Source Type: blogs
AbstractPurposeThe outcome of XEN implantation in Chinese eyes has not been previously reported. The purpose of our study is to evaluate the efficacy and safety of combined cataract surgery and XEN implantation in Chinese eyes with glaucoma.MethodsWe conducted a prospective study of 31 consecutive Chinese patients who underwent combined phacoemulsification and XEN implantation at the National University Hospital (Singapore) in this study. Patients were assessed preoperatively and postoperatively on days  1 and 7, and months 1, 3, 6, and 12. The intraocular pressure (IOP), glaucoma medication use, Snellen visual a...
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Egypt Health | Eyes | Glaucoma | Lucentis | Opthalmology | Ranibizumab Injection | Study | Vitamin A